ATMPs

The benefits of focussing on mission-driven outcomes for innovation, agility, and creativity

Dynamic Shared Ownership (DSO) at Bayer

With Dynamic Shared Ownership (DSO), Bayer has reimagined how a multinational company operates — replacing layers of hierarchy with self‑organised, entrepreneurial teams empowered to innovate faster and closer to the customer. With 95% of decisions now made by those closest to the customer, DSO shifts the focus from bureaucracy and annual budget cycles to mission‑driven outcomes delivered in rapid 90‑day cycles. The ambition: the scale of a multinational with the speed of a start‑up. In this interview, we explore what it takes to bring such a radical transformation to life at a local level.

"By focussing more on achieving mission-driven outcomes rather than working towards detailed KPIs (key performance indicators), we’ve become more responsive and agile, enabling us to deliver faster innovation to our customers."

Niels Hessmann, Managing Director and Country Division Head Pharmaceuticals at Bayer BNL

Ilse Kennes, Director at PwC Belgium, spoke to Niels Hessmann, Managing Director and Country Division Head Pharmaceuticals at Bayer Benelux (BNL), about his experiences implementing DSO at Bayer BNL, what the operating model aims to achieve, and his recommendations for companies in similar circumstances.

Read our interview for the full story.

Implementing DSO at Bayer BNL

Download our interview with Niels Hessmann to discover the benefits of DSO and what your organisation could learn from it.

Contact us

Matthias Reyntjens

Matthias Reyntjens

Partner, Clients and Industries, PwC Belgium

Tel: +32 476 44 53 92

Jan Debaere

Jan Debaere

Partner, Health Industries Lead, PwC Belgium

Tel: +32 473 92 46 11

Ilse Kennes

Ilse Kennes

Director, Health Industries, PwC Belgium

Tel: +32 477 62 58 71

Michele Paque

Michele Paque

External Senior Advisor, Health Industries, PwC Belgium

Tel: +32 477 60 50 51

Connect with PwC Belgium